Your browser doesn't support javascript.
loading
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women.
Hoyles, Lesley; Fernández-Real, José-Manuel; Federici, Massimo; Serino, Matteo; Abbott, James; Charpentier, Julie; Heymes, Christophe; Luque, Jèssica Latorre; Anthony, Elodie; Barton, Richard H; Chilloux, Julien; Myridakis, Antonis; Martinez-Gili, Laura; Moreno-Navarrete, José Maria; Benhamed, Fadila; Azalbert, Vincent; Blasco-Baque, Vincent; Puig, Josep; Xifra, Gemma; Ricart, Wifredo; Tomlinson, Christopher; Woodbridge, Mark; Cardellini, Marina; Davato, Francesca; Cardolini, Iris; Porzio, Ottavia; Gentileschi, Paolo; Lopez, Frédéric; Foufelle, Fabienne; Butcher, Sarah A; Holmes, Elaine; Nicholson, Jeremy K; Postic, Catherine; Burcelin, Rémy; Dumas, Marc-Emmanuel.
Afiliação
  • Hoyles L; Division of Integrative Systems Medicine and Digestive Diseases, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Fernández-Real JM; Department of Endocrinology, Diabetes and Nutrition and Department of Medicine, Hospital of Girona "Dr Josep Trueta", Universitat of Girona and CIBERobn Pathophysiology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain. jmfreal@idibgi.org.
  • Federici M; Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier, Rome, Italy. federicm@uniroma2.it.
  • Serino M; Institut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France.
  • Abbott J; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: 'Intestinal Risk Factors, Diabetes, Dyslipidemia, and Heart Failure', Toulouse, France.
  • Charpentier J; Division of Integrative Systems Medicine and Digestive Diseases, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Heymes C; Institut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France.
  • Luque JL; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: 'Intestinal Risk Factors, Diabetes, Dyslipidemia, and Heart Failure', Toulouse, France.
  • Anthony E; Institut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France.
  • Barton RH; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: 'Intestinal Risk Factors, Diabetes, Dyslipidemia, and Heart Failure', Toulouse, France.
  • Chilloux J; Department of Endocrinology, Diabetes and Nutrition and Department of Medicine, Hospital of Girona "Dr Josep Trueta", Universitat of Girona and CIBERobn Pathophysiology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain.
  • Myridakis A; Institut Cochin Inserm U1016 CNRS UMR 8104, Université Paris Descartes, Paris, France.
  • Martinez-Gili L; Division of Integrative Systems Medicine and Digestive Diseases, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Moreno-Navarrete JM; Division of Integrative Systems Medicine and Digestive Diseases, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Benhamed F; Division of Integrative Systems Medicine and Digestive Diseases, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Azalbert V; Division of Integrative Systems Medicine and Digestive Diseases, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Blasco-Baque V; Department of Endocrinology, Diabetes and Nutrition and Department of Medicine, Hospital of Girona "Dr Josep Trueta", Universitat of Girona and CIBERobn Pathophysiology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain.
  • Puig J; Institut Cochin Inserm U1016 CNRS UMR 8104, Université Paris Descartes, Paris, France.
  • Xifra G; Institut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France.
  • Ricart W; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: 'Intestinal Risk Factors, Diabetes, Dyslipidemia, and Heart Failure', Toulouse, France.
  • Tomlinson C; Institut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France.
  • Woodbridge M; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: 'Intestinal Risk Factors, Diabetes, Dyslipidemia, and Heart Failure', Toulouse, France.
  • Cardellini M; Department of Endocrinology, Diabetes and Nutrition and Department of Medicine, Hospital of Girona "Dr Josep Trueta", Universitat of Girona and CIBERobn Pathophysiology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain.
  • Davato F; Department of Endocrinology, Diabetes and Nutrition and Department of Medicine, Hospital of Girona "Dr Josep Trueta", Universitat of Girona and CIBERobn Pathophysiology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain.
  • Cardolini I; Department of Endocrinology, Diabetes and Nutrition and Department of Medicine, Hospital of Girona "Dr Josep Trueta", Universitat of Girona and CIBERobn Pathophysiology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain.
  • Porzio O; Division of Integrative Systems Medicine and Digestive Diseases, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Gentileschi P; Division of Integrative Systems Medicine and Digestive Diseases, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Lopez F; Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier, Rome, Italy.
  • Foufelle F; Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier, Rome, Italy.
  • Butcher SA; Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier, Rome, Italy.
  • Holmes E; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Nicholson JK; Department of Laboratory Medicine, Bambino Gesù Children's Hospital, Rome, Italy.
  • Postic C; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Burcelin R; Institut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France.
  • Dumas ME; Université Paul Sabatier (UPS), Unité Mixte de Recherche (UMR) 1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Team 2: 'Intestinal Risk Factors, Diabetes, Dyslipidemia, and Heart Failure', Toulouse, France.
Nat Med ; 24(7): 1070-1080, 2018 07.
Article em En | MEDLINE | ID: mdl-29942096
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Metagenômica / Hepatopatia Gordurosa não Alcoólica / Obesidade Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Metagenômica / Hepatopatia Gordurosa não Alcoólica / Obesidade Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos